Evidence map›Paper›PMID 26600189›Full record

ArticlePloS one2015

Tissue Specificity of Human Angiotensin I-Converting Enzyme.

Olga V Kryukova, Victoria E Tikhomirova, Elena Z Golukhova, Valery V Evdokimov, Gavreel F Kalantarov, Ilya N Trakht, David E Schwartz, Randal O Dull, Alexander V Gusakov, Igor V Uporov and 2 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Epitope mapping of novel monoclonal antibodies to human angiotensin I-converting enzyme.Protein science : a publication of the Protein Society · 2021
    Article
  10. Article
  11. Article
  12. ACE phenotyping in Gaucher disease.Molecular genetics and metabolism · 2018
    Article
  13. Article
  14. Article
  15. Article
  16. The Impact ofIn vivo (Athens, Greece)
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Olga V KryukovaChemical Faculty, M.V.Lomonosov Moscow State University, Moscow, Russia.
Victoria E TikhomirovaChemical Faculty, M.V.Lomonosov Moscow State University, Moscow, Russia.
Elena Z GolukhovaBakulev Center for Cardiovascular Surgery, Moscow, Russia.
Valery V EvdokimovInstitute of Urology, Moscow, Russia.
Gavreel F KalantarovDepartment of Medicine, Columbia University, New York, NY, United States of America.
Ilya N TrakhtDepartment of Medicine, Columbia University, New York, NY, United States of America.
David E SchwartzDepartment of Anesthesiology, University of Illinois at Chicago, Chicago, IL, United States of America.
Randal O DullDepartment of Anesthesiology, University of Illinois at Chicago, Chicago, IL, United States of America.
Alexander V GusakovChemical Faculty, M.V.Lomonosov Moscow State University, Moscow, Russia.
Igor V UporovChemical Faculty, M.V.Lomonosov Moscow State University, Moscow, Russia.
Olga A KostChemical Faculty, M.V.Lomonosov Moscow State University, Moscow, Russia.
Sergei M DanilovDepartment of Anesthesiology, University of Illinois at Chicago, Chicago, IL, United States of America.
Lomonosov Moscow State University · RUUniversity of Illinois Chicago · USColumbia University · USBakulev Scientific Center for Cardiovascular Surgery Russian Academy of Medical Sciences · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAngiotensin-converting enzyme (ACE), which metabolizes many peptides and plays a key role in blood pressure regulation and vascular remodeling, as well as in reproductive functions, is expressed as a type-1 membrane glycoprotein on the surface of endothelial and epithelial cells. ACE also presents as a soluble form in biological fluids, among which seminal fluid being the richest in ACE content - 50-fold more than that in blood. METHODS/PRINCIPAL

findingsWe performed conformational fingerprinting of lung and seminal fluid ACEs using a set of monoclonal antibodies (mAbs) to 17 epitopes of human ACE and determined the effects of potential ACE-binding partners on mAbs binding to these two different ACEs. Patterns of mAbs binding to ACEs from lung and from seminal fluid dramatically differed, which reflects difference in the local conformations of these ACEs, likely due to different patterns of ACE glycosylation in the lung endothelial cells and epithelial cells of epididymis/prostate (source of seminal fluid ACE), confirmed by mass-spectrometry of ACEs tryptic digests.

conclusionsDramatic differences in the local conformations of seminal fluid and lung ACEs, as well as the effects of ACE-binding partners on mAbs binding to these ACEs, suggest different regulation of ACE functions and shedding from epithelial cells in epididymis and prostate and endothelial cells of lung capillaries. The differences in local conformation of ACE could be the base for the generation of mAbs distingushing tissue-specific ACEs.

Indexed as

Antibodies, MonoclonalEndothelial CellsEpididymisEpitope MappingHumansLungMalePeptidyl-Dipeptidase AProstateSemenACE protein, humanAntibodies, MonoclonalPeptidyl-Dipeptidase A

Identifiers

PMID26600189
PMCPMC4658169
OpenAlexW2280100042

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.